For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
To save medical costs,many patients choose to accpet infusion treatment at home under doctors' supervision and guidance.
LPI (LP Information)' newest research report, the "Home Infusion Therapy Industry Forecast" looks at past sales and reviews total world Home Infusion Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Home Infusion Therapy sales for 2023 through 2029. With Home Infusion Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Home Infusion Therapy industry.
This Insight Report provides a comprehensive analysis of the global Home Infusion Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Home Infusion Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Home Infusion Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Home Infusion Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Home Infusion Therapy.
The global Home Infusion Therapy market size is projected to grow from US$ 19410 million in 2022 to US$ 29290 million in 2029; it is expected to grow at a CAGR of 6.0% from 2023 to 2029.
The growing healthcare expenditure level is a key concern amongst patients and governments worldwide, necessitating the implementation of effective measures to curb these costs. Hence, the home healthcare option serves as a cost-effective alternative to expensive hospital stays, which is expected to serve this market as a high impact rendering driver throughout the forecast period. Moreover, increasing awareness about the high prevalence of hospital-acquired infections is anticipated to accentuate the importance of home healthcare.
This report presents a comprehensive overview, market shares, and growth opportunities of Home Infusion Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Infusion Pumps
- Intravenous Sets
- IV Cannulas
- Needleless Connectors
Segmentation by application
- Anti-Infectives
- Endocrinology
- Hydration Therapy
- Chemotherapy
- Enteral Nutrition
- Parenteral Nutrition
- Specialty Pharmaceuticals
- Others
This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- Baxter
- Caesarea Medical Electronics
- B.Braun Melsungen AG
- CareFusion Corporation
- ICU Medical?Inc.
- Fresenius Kabi AG
- JMS Co.Ltd
- Terumo Corporation
- Smiths Medical